Search results
Results from the WOW.Com Content Network
[1] [3] It is estimated that type 1 diabetics experience two mild, symptomatic episodes of hypoglycemia per week. [3] Additionally, people with type 1 diabetes have at least one severe hypoglyemic episode per year, requiring treatment assistance. [3] In terms of mortality, hypoglycemia causes death in 6–10% of type 1 diabetics. [3 ...
Severe hypoglycemia rarely, if ever, occurs in people with diabetes treated only with diet, exercise, or insulin sensitizers. For people with insulin-requiring diabetes, hypoglycemia is one of the recurrent hazards of treatment. It limits the achievability of normal glucoses with current treatment methods.
In insulin-dependent diabetic patients this phenomenon is termed hypoglycemia unawareness and is a significant clinical problem when improved glycemic control is attempted. Another aspect of this phenomenon occurs in type I glycogenosis , when chronic hypoglycemia before diagnosis may be better tolerated than acute hypoglycemia after treatment ...
The mainstay of physiologic ketotic hypoglycemia treatment typically includes management of the underlying cause, fluid resuscitation, and dietary supplementation of sugars and carbohydrates. [2] Alanine is a direct precursor in gluconeogenesis and can be used for treatment of ketotic hypoglycemia.
Reactive hypoglycemia, postprandial hypoglycemia, or sugar crash is a term describing recurrent episodes of symptomatic hypoglycemia occurring within four hours [1] after a high carbohydrate meal in people with and without diabetes. [2] The term is not necessarily a diagnosis since it requires an evaluation to determine the cause of the ...
Recurrent mild hypoglycemia may fit a reactive hypoglycemia pattern, but this is also the peak age for idiopathic postprandial syndrome, and recurrent "spells" in this age group can be traced to orthostatic hypotension or hyperventilation as often as demonstrable hypoglycemia. [citation needed] Insulin-induced hypoglycemia
A 2004 statement by the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society (for children) uses slightly different cutoffs, where mild DKA is defined by pH 7.20–7.30 (bicarbonate 10–15 mmol/L), moderate DKA by pH 7.1–7.2 (bicarbonate 5–10) and severe DKA by pH<7.1 (bicarbonate below 5).
The goal of treatment in hyperinsulinism is to prevent hypoglycemia-induced brain damage, thus, the goal of therapy is to maintain the blood sugar level in the normal range [>70 mg/dL (3.9 mmol/L)]. The first step is the restoration of blood sugar level to the normal range after acute hypoglycemia, followed by the prevention of recurrent ...